Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Talis Biomedical Corporation and Encourages Investors with Substantial Losses to Contact the Firm

Author's Avatar
Jan 17, 2022

The law firm of Kessler+Topaz+Meltzer+%26amp%3B+Check%2C+LLP informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation (“Talis”) (NASDAQ%3A+TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Talis’ materially misleading statements to the public, Talis investors have suffered significant losses.